Purchases and Sales Made in Q3 2024 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q3 2024. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Octagon Capital Advisors LP
New York, NY |
BUY
|
- |
8.56MNew |
$2.05M - $4.62M
|
8.56M
$6.93M
|
|
Nov 13, 2024
Q3 2024
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
- |
8.56MNew |
$2.05M - $4.62M
|
8.56M
$6.93M
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
5MNew |
$1.2M - $2.7M
|
5M
$4.05M
|
|
Nov 14, 2024
Q3 2024
|
Silverarc Capital Management, LLC
|
BUY
|
- |
4MNew |
$960K - $2.16M
|
4M
$3.24M
|
|
Nov 14, 2024
Q3 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
2.25MNew |
$540K - $1.22M
|
2.25M
$1.82M
|
|
Nov 14, 2024
Q3 2024
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
1.98MNew |
$475K - $1.07M
|
1.98M
$1.6M
|
|
Nov 14, 2024
Q3 2024
|
Logos Global Management LP
San Francisco, CA |
BUY
|
- |
1.61M+ 46.37% |
$386K - $869K
|
5.08M
$4.11M
|
|
Nov 14, 2024
Q3 2024
|
Altium Capital Management LP
New York, NY |
BUY
|
- |
1.47MNew |
$354K - $795K
|
1.47M
$1.19M
|
|
Nov 13, 2024
Q3 2024
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
1M+ 28.82% |
$240K - $540K
|
4.47M
$3.62M
|
|
Nov 08, 2024
Q3 2024
|
Lpl Financial LLC
Fort Mill, SC |
BUY
|
- |
381K+ 448.24% |
$91.4K - $206K
|
466K
$377K
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
117K+ 40.83% |
$28K - $63K
|
402K
$326K
|
|
Oct 16, 2024
Q3 2024
|
Bleakley Financial Group, LLC
Fairfield, NJ |
BUY
|
- |
80KNew |
$19.2K - $43.2K
|
80K
$64.8K
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
70.8KNew |
$17K - $38.2K
|
70.8K
$57.3K
|
|
Nov 20, 2024
Q3 2024
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
62.9K+ 566.8% |
$15.1K - $34K
|
74K
$59.9K
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
41.2KNew |
$9.9K - $22.3K
|
41.2K
$33.4K
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
23.3KNew |
$5.58K - $12.6K
|
23.3K
$18.8K
|
|
Oct 11, 2024
Q3 2024
|
Creative Planning
Overland Park, KS |
BUY
|
- |
10.2KNew |
$2.46K - $5.52K
|
10.2K
$8.29K
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
4.3K+ 23.25% |
$1.03K - $2.32K
|
22.8K
$18.5K
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
137+ 195.71% |
$32.9 - $74
|
207
$168
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
109+ 48.88% |
$26.2 - $58.9
|
332
$269
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
72+ 0.08% |
$17.3 - $38.9
|
93.4K
$75.7K
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|